Works matching DE "REVERSE transcriptase inhibitors"
Results: 632
Gender Differences in HIV Drug Resistance Mutations and Virological Outcome.
- Published in:
- Journal of Women's Health (15409996), 2011, v. 20, n. 1, p. 117, doi. 10.1089/jwh.2009.1846
- By:
- Publication type:
- Article
Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 231, doi. 10.3390/vaccines9030231
- By:
- Publication type:
- Article
High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5567332
- By:
- Publication type:
- Article
Discovery of Benzisothiazolone Derivatives as Bifunctional Inhibitors of HIV-1 Reverse Transcriptase DNA Polymerase and Ribonuclease H Activities.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 7, p. 819, doi. 10.3390/biom14070819
- By:
- Publication type:
- Article
Ageing with HIV: do comorbidities and polymedication drive treatment optimization?
- Published in:
- HIV Medicine, 2017, v. 18, n. 6, p. 395, doi. 10.1111/hiv.12441
- By:
- Publication type:
- Article
Finding of nevirapine extended release tablet remnants in stools does not threaten the success of combination antiretroviral therapy.
- Published in:
- HIV Medicine, 2014, v. 15, n. 2, p. 124, doi. 10.1111/hiv.12090
- By:
- Publication type:
- Article
Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues.
- Published in:
- HIV Medicine, 2013, v. 14, n. 9, p. 571, doi. 10.1111/hiv.12044
- By:
- Publication type:
- Article
Long-term beneficial effect of protease inhibitors on the intrinsic apoptosis of peripheral blood mononuclear cells in HIV-infected patients.
- Published in:
- HIV Medicine, 2012, v. 13, n. 8, p. 469, doi. 10.1111/j.1468-1293.2012.00999.x
- By:
- Publication type:
- Article
No increased risk of hepatotoxicity in long-term use of nonnucleoside reverse transcriptase inhibitors in HIV-infected patients.
- Published in:
- HIV Medicine, 2012, v. 13, n. 7, p. 448, doi. 10.1111/j.1468-1293.2012.00995.x
- By:
- Publication type:
- Article
Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.
- Published in:
- HIV Medicine, 2012, v. 13, n. 3, p. 166, doi. 10.1111/j.1468-1293.2011.00955.x
- By:
- Publication type:
- Article
Treatment limitations imposed by antiretroviral drug resistance mutations: implication for choices of first line regimens in resource-limited settings.
- Published in:
- HIV Medicine, 2012, v. 13, n. 3, p. 141, doi. 10.1111/j.1468-1293.2011.00950.x
- By:
- Publication type:
- Article
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI.
- Published in:
- HIV Medicine, 2012, v. 13, n. 1, p. 62, doi. 10.1111/j.1468-1293.2011.00943.x
- By:
- Publication type:
- Article
Influence of adding etravirine on complexity index and patients' perceived complexity.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 2, p. 154, doi. 10.1111/jcpt.12120
- By:
- Publication type:
- Article
Melatonin protects against tenofovir-induced nephrotoxicity in rats by targeting multiple cellular pathways.
- Published in:
- Human & Experimental Toxicology, 2021, v. 40, n. 5, p. 826, doi. 10.1177/0960327120968860
- By:
- Publication type:
- Article
Retrotransposon instability dominates the acquired mutation landscape of mouse induced pluripotent stem cells.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-35180-x
- By:
- Publication type:
- Article
Infectivity of Homologous Recombinant HIV-1 Pseudo-virus with Reverse Transcriptase Inhibitor-related Mutations from Highly Active Antiretroviral Therapy Experienced Patients
- Published in:
- Osong Public Health & Research Perspectives, 2011, v. 2, n. 1, p. 23, doi. 10.1016/j.phrp.2011.04.006
- By:
- Publication type:
- Article
Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling, Synthesis and Biological Evaluation.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2022, v. 21, n. 1, p. 1, doi. 10.5812/ijpr.123827
- By:
- Publication type:
- Article
A simple, rapid, economical, and practical method for the determination of efavirenz in plasma of Chinese AIDS patients by reverse phase high-performance liquid chromatography with ultraviolet detector.
- Published in:
- BioScience Trends, 2014, v. 8, n. 4, p. 227, doi. 10.5582/bst.2014.01002
- By:
- Publication type:
- Article
Tenofovir-induced delayed nephro-osteo toxicity.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Update on HIV Infection and Efficacy of Preventive Treatment.
- Published in:
- MEDSURG Nursing, 2021, v. 30, n. 1, p. 41, doi. 10.62116/msj.2021.30.1.41
- By:
- Publication type:
- Article
Protease inhibitor treatment in HIV pregnant women. Is it safe for newborns?
- Published in:
- 2002
- By:
- Publication type:
- journal article
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell Lines.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1615, doi. 10.3390/ijms25031615
- By:
- Publication type:
- Article
Lamivudine (3TC), a Nucleoside Reverse Transcriptase Inhibitor, Prevents the Neuropathological Alterations Present in Mutant Tau Transgenic Mice.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 11144, doi. 10.3390/ijms241311144
- By:
- Publication type:
- Article
In Vitro Susceptibility of HIV Isolates with High Growth Capability to Antiretroviral Drugs.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 15380, doi. 10.3390/ijms232315380
- By:
- Publication type:
- Article
A New Approach to Developing Long-Acting Injectable Formulations of Anti-HIV Drugs: Poly(Ethylene Phosphoric Acid) Block Copolymers Increase the Efficiency of Tenofovir against HIV-1 in MT-4 Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 1, p. 340, doi. 10.3390/ijms22010340
- By:
- Publication type:
- Article
On the Single-Crystal Structure of Tenofovir Alafenamide Mono-Fumarate: A Metastable Phase Featuring a Mixture of Co-Crystal and Salt.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 23, p. 9213, doi. 10.3390/ijms21239213
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of 2-Thioxopyrimidin-4(1H)-one Derivatives as Potential Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 11, p. 20723, doi. 10.3390/ijms151120723
- By:
- Publication type:
- Article
Severe eye complications from toxic epidermal necrolysis following initiation of Nevirapine based HAART regimen in a child with HIV infection: a case from Cameroon.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study.
- Published in:
- BMC Health Services Research, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12913-015-0959-0
- By:
- Publication type:
- Article
Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition.
- Published in:
- BMC Biochemistry, 2011, v. 12, n. 1, p. 18, doi. 10.1186/1471-2091-12-18
- By:
- Publication type:
- Article
The antiviral compound BIT225 inhibits HIV-1 replication in myeloid dendritic cells.
- Published in:
- AIDS Research & Therapy, 2016, v. 13, p. 1, doi. 10.1186/S12981-016-0093-Z
- By:
- Publication type:
- Article
HIV-1 Polymerase Inhibition by Nucleoside Analogs: Cellular- and Kinetic Parameters of Efficacy, Susceptibility and Resistance Selection.
- Published in:
- PLoS Computational Biology, 2012, v. 8, n. 1, p. 1
- By:
- Publication type:
- Article
Should we include connection domain mutations of HIV-1 reverse transcriptase in HIV resistance testing.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 10, p. 1, doi. 10.1002/jmv.29948
- By:
- Publication type:
- Article
High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre‐existing HIV resistance and suboptimal adherence.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 10, p. 1, doi. 10.1002/jmv.29899
- By:
- Publication type:
- Article
Pretreatment drug resistance among people living with HIV from 2018 to 2022 in Guangzhou, China.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 10, p. 1, doi. 10.1002/jmv.29937
- By:
- Publication type:
- Article
Utility of a Microphysiological 3D Model of the Human Kidney Proximal Tubule for Predictive Toxicity Testing.
- Published in:
- Blood Purification, 2017, v. 43, n. 1-3, p. 262, doi. 10.1159/000454962
- By:
- Publication type:
- Article
Biological evaluation of reverse transcriptase inhibition and antiviral activity against HIV-1 of Cyclopentanpyridinone analogues.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Development of pharmacophore models for predicting HIV-1 reverse transcriptase inhibitory activity of pyridinone derivatives.
- Published in:
- Pharmaceutical Chemistry Journal, 2011, v. 45, n. 1, p. 36, doi. 10.1007/s11094-011-0556-4
- By:
- Publication type:
- Article
Purification and characterization of a protein with antifungal, antiproliferative, and HIV-1 reverse transcriptase inhibitory activities from small brown-eyed cowpea seeds.
- Published in:
- Biotechnology & Applied Biochemistry, 2013, v. 60, n. 4, p. 393, doi. 10.1002/bab.1102
- By:
- Publication type:
- Article
Rapid viral suppression using integrase inhibitors during acute HIV-1 infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 1, p. 169, doi. 10.1093/jac/dkae391
- By:
- Publication type:
- Article
No accelerated progression of subclinical atherosclerosis with integrase strand transfer inhibitors compared to non-nucleoside reverse transcriptase inhibitors.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 1, p. 126, doi. 10.1093/jac/dkae383
- By:
- Publication type:
- Article
Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 1, p. 95, doi. 10.1093/jac/dkae377
- By:
- Publication type:
- Article
Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 10, p. 2575, doi. 10.1093/jac/dkae260
- By:
- Publication type:
- Article
Characterization of a case of virological failure after switch to long-acting cabotegravir and rilpivirine.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 8, p. 2074, doi. 10.1093/jac/dkae187
- By:
- Publication type:
- Article
Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 2, p. 287, doi. 10.1093/jac/dkad375
- By:
- Publication type:
- Article
HIV-1 resistance genotyping by ultra-deep sequencing and 6-month virological response to first-line treatment.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 2, p. 346, doi. 10.1093/jac/dkac391
- By:
- Publication type:
- Article
Intracellular islatravir pharmacology differs between species in an in vitro model: implications for preclinical study design.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection.
- Published in:
- 2021
- By:
- Publication type:
- Letter